Can a patient receiving hemodialysis via a mature arteriovenous fistula develop a catheter-related bloodstream infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Patients on AVF for Hemodialysis Develop CRBSI?

No, patients receiving hemodialysis through a mature arteriovenous fistula (AVF) cannot develop catheter-related bloodstream infection (CRBSI) because CRBSI is by definition an infection specifically caused by an intravascular catheter, which an AVF is not. 1, 2

Understanding the Terminology

The term "catheter-related bloodstream infection" (CRBSI) applies exclusively to infections originating from central venous catheters (CVCs), not arteriovenous fistulas or grafts. 1 This is a critical distinction:

  • CRBSI requires the presence of an intravascular catheter and is defined as isolation of the same organism from quantitative cultures of both the catheter and peripheral blood in a patient with clinical features of infection without another apparent source 1, 3
  • AVF-related infections are an entirely different entity, presenting as local access site infections or bacteremia, but are not classified as CRBSI 2, 4

AVF Infection Risk Profile

While AVFs cannot cause CRBSI, they do carry the lowest infection risk of all hemodialysis access types:

  • AVF infection rates: 1-4% over the entire lifetime of use, representing the lowest infection risk among all vascular access options 2
  • Bacteremia rates: 0.2 per 1,000 dialysis procedures with AVF 1
  • Relative risk: 7-fold lower bacteremia risk compared to catheters 1, 5

Infection Risk Hierarchy in Hemodialysis Access

Understanding the complete spectrum helps contextualize why the terminology matters:

  1. AVF (lowest risk): 0-11 bacteremia episodes per 100 patient-years 1
  2. AVG (intermediate risk): 11-20% infection rate during expected usage period 2
  3. Tunneled CVC: 1.6 infections per 1,000 catheter-days, with 50% removal due to infection at 1 year 2, 5
  4. Non-tunneled CVC (highest risk): 2.7 infections per 1,000 catheter-days 5

Clinical Implications

When evaluating a febrile hemodialysis patient with an AVF, consider AVF-related bacteremia as a potential diagnosis, but do not use the term CRBSI. 4 The diagnostic approach differs:

  • For catheter patients: Obtain paired blood cultures (one from catheter, one peripheral) to diagnose CRBSI 1, 3
  • For AVF patients: Obtain peripheral blood cultures and examine the access site for local infection signs (erythema, purulence, warmth) 1, 4

Common Pitfall to Avoid

Do not conflate all hemodialysis access-related infections with CRBSI. 4 This terminology error can lead to:

  • Inappropriate application of catheter-specific management guidelines to AVF infections 1
  • Misclassification in infection surveillance databases 1
  • Confusion regarding infection prevention strategies, as AVF and catheter infections have fundamentally different pathophysiology 2, 6

The 70-80% of patients who initiate dialysis with catheters are at risk for CRBSI, but once transitioned to a mature AVF, they are no longer susceptible to this catheter-specific complication. 6, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vascular Access with Lower Infection Risk in Hemodialysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Current Concepts in Hemodialysis Vascular Access Infections.

Advances in chronic kidney disease, 2019

Guideline

Central Venous Catheter Complications in Hemodialysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Practical Strategies for Prevention of Catheter-Related Bloodstream Infections (CRBSI) in United States Hemodialysis Facilities.

Hemodialysis international. International Symposium on Home Hemodialysis, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.